Cytokine secretion after cardiac surgery and its relationship to postoperative fever

Cytokine

Volumn 38, Issue 1, 2007, Pages 37-42

  Mitchell, John D ^a   Grocott, Hilary P ^a   Phillips Bute, Barbara ^a   Mathew, Joseph P ^a   Newman, Mark F ^a   Bar Yosef, Shahar ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiopulmonary bypass; Cytokines; IL 6; Inflammatory response

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; FEMALE; FEVER; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; CORONARY ARTERY BYPASS; CYTOKINES; FEMALE; FEVER; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SEX FACTORS;

EID: 34250865815     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.04.009     Document Type: Article

References (40)

1. Thong W.Y., Strickler A.G., Li S., Stewart E.E., Collier C.L., Vaughn W.K., et al. Hyperthermia in the forty-eight hours after cardiopulmonary bypass. Anesth Analg 95 6 (2002) 1489-1495
2. Hindman B.J. Emboli, inflammation, and CNS impairment: an overview. Heart Surg Forum 5 3 (2002) 249-253
3. Beamer N.B., Coull B.M., Clark W.M., Hazel J.S., and Silberger J.R. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 37 6 (1995) 800-805
4. Grocott H.P., Mackensen G.B., Grigore A.M., Mathew J., Reves J.G., Phillips-Bute B., et al. Postoperative hyperthermia is associated with cognitive dysfunction after coronary artery bypass graft surgery. Stroke 33 2 (2002) 537-541
5. Cook D.J. Cerebral hyperthermia and cardiac surgery: consequences and prevention. Semin Thorac Cardiovasc Surg 13 2 (2001) 176-183
6. Reith J., Jorgensen H.S., Pedersen P.M., Nakayama H., Raaschou H.O., Jeppesen L.L., et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 347 8999 (1996) 422-425
7. Wass C.T., Lanier W.L., Hofer R.E., Scheithauer B.W., and Andrews A.G. Temperature changes of > or = 1 degree C alter functional neurologic outcome and histopathology in a canine model of complete cerebral ischemia. Anesthesiology 83 2 (1995) 325-335
8. Tuman K.J., McCarthy R.J., Najafi H., and Ivankovich A.D. Differential effects of advanced age on neurologic and cardiac risks of coronary artery operations. J Thorac Cardiovasc Surg 104 6 (1992) 1510-1517
9. Blatteis C.M. The afferent signalling of fever. J Physiol 526 Pt 3 (2000) 470
10. Leon L.R. Invited review: cytokine regulation of fever: studies using gene knockout mice. J Appl Physiol 92 6 (2002) 2648-2655
11. De Jongh R.F., Vissers K.C., Booij L.H., De Jongh K.L., Vincken P., and Meert T.F. Interleukin-6 and perioperative thermoregulation and HPA-axis activation. Cytokine 21 5 (2003) 248-256
12. Sharma M., Ganguly N.K., Chaturvedi G., Thingnam S.K., Majumdar S., and Suri R.K. Release of pro-inflammatory mediators during myocardial ischemia/reperfusion in coronary artery bypass graft surgery. Mol Cell Biochem 247 1-2 (2003) 23-30
13. Steinberg J.B., Kapelanski D.P., Olson J.D., and Weiler J.M. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 106 6 (1993) 1008-1016
14. Frering B., Philip I., Dehoux M., Rolland C., Langlois J.M., and Desmonts J.M. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 108 4 (1994) 636-641
15. Hennein H.A., Ebba H., Rodriguez J.L., Merrick S.H., Keith F.M., Bronstein M.H., et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 108 4 (1994) 626-635
16. Rothenburger M., Soeparwata R., Deng M.C., Schmid C., Berendes E., Tjan T.D., et al. Prediction of clinical outcome after cardiac surgery: the role of cytokines, endotoxin, and anti-endotoxin core antibodies. Shock 16 Suppl. 1 (2001) 44-50
17. Burzotta F., Iacoviello L., Di Castelnuovo A., Glieca F., Luciani N., Zamparelli R., et al. Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol 88 10 (2001) 1125-1128
18. Gaudino M., Andreotti F., Zamparelli R., Di Castelnuovo A., Nasso G., Burzotta F., et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?. Circulation 108 Suppl. 1 (2003) II195-II199
19. Frank S.M., Kluger M.J., and Kunkel S.L. Elevated thermostatic setpoint in postoperative patients. Anesthesiology 93 6 (2000) 1426-1431
20. Andres B.M., Taub D.D., Gurkan I., and Wenz J.F. Postoperative fever after total knee arthroplasty: the role of cytokines. Clin Orthop 415 (2003) 221-231
21. Miyawaki T., Maeda S., Koyama Y., Fukuoka R., and Shimada M. Elevation of plasma interleukin-6 level is involved in postoperative fever following major oral and maxillofacial surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 2 (1998) 146-152
22. Lahat N., Zlotnick A.Y., Shtiller R., Bar I., and Merin G. Serum levels of IL-1, IL-6 and tumour necrosis factors in patients undergoing coronary artery bypass grafts or cholecystectomy. Clin Exp Immunol 89 2 (1992) 255-260
23. Holzheimer R.G., Molloy R.G., Gorlach H., Wilkert S., and Hehrlein F. IL-6 and TNF alpha release in association with neutrophil activation after cardiopulmonary bypass surgery. Infection 22 1 (1994) 37-42
24. Chello M., Mastroroberto P., Quirino A., Cuda G., Perticone F., Cirillo F., et al. Inhibition of neutrophil apoptosis after coronary bypass operation with cardiopulmonary bypass. Ann Thorac Surg 73 1 (2002) 123-129 discussion 9-30
25. Gerriets T., Stolz E., Walberer M., Kaps M., Bachmann G., and Fisher M. Neuroprotective effects of MK-801 in different rat stroke models for permanent middle cerebral artery occlusion: adverse effects of hypothalamic damage and strategies for its avoidance. Stroke 34 9 (2003) 2234-2239
26. Newman M.F., Kirchner J.L., Phillips-Bute B., Gaver V., Grocott H., Jones R.H., et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 344 6 (2001) 395-402
27. Kim J.S., Yoon S.S., Kim Y.H., and Ryu J.S. Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. Stroke 27 9 (1996) 1553-1557
28. Herrmann O., Tarabin V., Suzuki S., Attigah N., Coserea I., Schneider A., et al. Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia. J Cereb Blood Flow Metab 23 4 (2003) 406-415
29. Zetterstrom M., Sundgren-Andersson A.K., Ostlund P., and Bartfai T. Delineation of the proinflammatory cytokine cascade in fever induction. Ann N Y Acad Sci 856 (1998) 48-52
30. Shenkin A., Fraser W.D., Series J., Winstanley F.P., McCartney A.C., Burns H.J., et al. The serum interleukin 6 response to elective surgery. Lymphokine Res 8 2 (1989) 123-127
31. Kawamura T., Inada K., Nara N., Wakusawa R., and Endo S. Influence of methylprednisolone on cytokine balance during cardiac surgery. Crit Care Med 27 3 (1999) 545-548
32. Greilich P.E., Brouse C.F., Whitten C.W., Chi L., Dimaio J.M., and Jessen M.E. Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin. J Thorac Cardiovasc Surg 126 5 (2003) 1498-1503
33. Freyholdt T., Massoudy P., Zahler S., Henze R., Barankay A., Becker B.F., et al. Beneficial effect of sodium nitroprusside after coronary artery bypass surgery: pump function correlates inversely with cardiac release of proinflammatory cytokines. J Cardiovasc Pharmacol 42 3 (2003) 372-378
34. Defraigne J.O., Pincemail J., Larbuisson R., Blaffart F., and Limet R. Cytokine release and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration. Ann Thorac Surg 69 4 (2000) 1084-1091
35. Butler J., Murithi E.W., Pathi V.L., MacArthur K.J., and Berg G.A. Duroflo II heparin bonding does not attenuate cytokine release or improve pulmonary function. Ann Thorac Surg 74 1 (2002) 139-142
36. Grunenfelder J., Zund G., Schoeberlein A., Schmid E.R., Schurr U., Frisullo R., et al. Expression of adhesion molecules and cytokines after coronary artery bypass grafting during normothermic and hypothermic cardiac arrest. Eur J Cardiothorac Surg 17 6 (2000) 723-728
37. Wan S., Izzat M.B., Lee T.W., Wan I.Y., Tang N.L., and Yim A.P. Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury. Ann Thorac Surg 68 1 (1999) 52-56 discussion 6-7
38. Markewitz A., Faist E., Lang S., Endres S., Hultner L., and Reichart B. Regulation of acute phase response after cardiopulmonary bypass by immunomodulation. Ann Thorac Surg 55 2 (1993) 389-394
39. Paparella D., Yau T.M., and Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 21 2 (2002) 232-244
40. Misoph M., and Babin-Ebell J. Interindividual variations in cytokine levels following cardiopulmonary bypass. Heart Vessels 12 3 (1997) 119-127